{"nct_id":"NCT01617967","title":"Safety and Tolerability of Patisiran (ALN-TTR02) in Transthyretin (TTR) Amyloidosis","status":"COMPLETED","status_verified_date":"2018-10","start_date":"2012-05","start_date_type":null,"primary_completion_date":"2013-10","primary_completion_date_type":"ACTUAL","completion_date":"2014-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ALNY"]}